Form 4: DarioHealth Director Buys Shares
Insider Transaction (Form 4)
Dennis Matheis, a Director of DarioHealth Corp., purchased 14,430 shares of common stock on August 12, 2024 for $6.93 per share.
Summary
- Conversion of derivative: acquired 965 Common Stock at $19.10 ($18,432) on August 12, 2024; holds 28,596 after (Direct).
- Open-market purchase: acquired 14,430 Common Stock at $6.93 ($100,000) on July 23, 2026; holds 43,026 after (Direct).
- Conversion of derivative: disposed of 50 Series B-2 Preferred Stock at $1,000.00 ($50,000) on August 12, 2024 (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $100,000, committing personal capital to the stock.
Insider Transactions
Dennis Matheis — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2024-08-12 | Conversion of derivative | Common Stock | 965 | $19 | $18.4K | 28,596 |
| 2026-07-23 | Open-market purchase | Common Stock | 14,430 | $7 | $100.0K | 43,026 |
| 2024-08-12 | Conversion of derivative | Series B-2 Preferred Stock | 50 | $1.0K | $50.0K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2024-08-12 | Conversion of derivative (965 shares) |
| 2026-07-23 | Open-market purchase (14,430 shares) |
| 2024-08-12 | Conversion of derivative (50 shares) |
Keywords
insider transaction, Form 4, DRIO, DarioHealth Corp., bullish, Dennis Matheis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.